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Small cystine-stabilized proteins are desirable scaf-
folds for therapeutics and diagnostics. Specific
folding and binding properties of the proteinaceous
binders canbe engineeredwith combinatorial protein
libraries in connection with artificial molecular evolu-
tion. The combinatorial protein libraries are com-
posed of scaffold variants with random sequence
variation, which inevitably produces a portion of the
library sequences incompatiblewith theparent struc-
ture. Here, we used artificial molecular evolution to
elucidate structure-determining residues in a small-
est cystine-stabilized scaffold. The structural deter-
minant information was then applied to designing
cystine-stabilized miniproteins binding to human
vascular endothelial growth factor. Thiswork demon-
strated a general methodology on engineering artifi-
cial cystine-stabilized proteins as antibody mimetics
with simultaneously enhanced folding and binding
properties.
INTRODUCTION
Small cystine-stabilized proteins as scaffolds for proteinaceous
binders are advantageous (Craik et al., 2006; Smith et al.,
1998; Silverman et al., 2005) in that the cystine cross-linkedmini-
protein structures are stable in extreme conditions and are rela-
tively easy to produce (Smith et al., 1998; Silverman et al., 2005;
Souriau et al., 2005). The underlying rationale for this direction
was attained from a large number of naturally occurring cases.
One set of examples are knottins, a large family (more than
1200 known sequence members to date) (Gracy et al., 2008)
of small (<50 residues) cystine-stabilized proteins for which
the main biological function is molecular recognition on proteins,
sugars, and lipids. These proteins provide a rich source of
potentially useful scaffolds for ever expanding applications in
molecular recognition.620 Structure 17, 620–631, April 15, 2009 ª2009 Elsevier Ltd All righMonoclonal antibodies and their recombinant fragments are
the mainstream scaffolds in protein recognition engineering,
but alternative nonantibody scaffolds are frequently desirable
to overcome the limitations imposed by antibody production
and storage (Skerra, 2007). To design antibody mimetics, we
constructed repertoires of combinatorial protein-recognition
surfaces on a small cystine-stabilized scaffold with a spatially
contiguous patch composed of two discontinuous variable
sequence segments. Such protein recognition surfaces mimic
antibody variable domain paratope structures, which are
composed of sequence-wise distant complementarity deter-
mining regions (CDRs) forming a spatially contiguous antigen
recognition surface. In conjunction with powerful phage
display-based artificial molecular evolution (Silverman et al.,
2005; Skerra, 2007; Hsu et al., 2008, 2006; Ladner et al., 2004;
Sidhu et al., 2003; Lowman, 1997), the large repertoires of combi-
natorial proteins are important tools enabling protein engineering
processes mimicking in vivo antibody-antigen interaction selec-
tion and reinforcement.
Engineering protein binding needs insight into protein folding.
The reason is that recognition surfaces are frequently preassem-
bled from sequence-wise distant segments, arranged in close
proximity in space through a stably folded structure (Wodak and
Janin, 2002). The sequence design in this work was based on a
23-residue autonomous folding unit (dubbed Min-23) (Heitz
et al., 1999) from EETI-II (ecballium elaterium trypsin inhibitor II,
a member of the knottin family) with four cysteines forming 1-3/
2-4disulfidebondingconfiguration (Souriauetal., 2005).Structural
determinant information is essential in determining invariable resi-
dues, which are indispensable in supporting the targeting surfaces
on the scaffold as designed. The folding mechanisms of Min-23
(Heitz et al., 1999) and its parent protein EETI-II (Heitz et al.,
1995; Wentzel et al., 1999; Le-Nguyen et al., 1993) have been
well-characterized, but the structural determinants underlying the
native disulfide bonding configuration are not clearly understood.
Structural determinant information has been difficult to attain.
Although successes in consensus-based protein engineering
approaches (Kajander et al., 2006) have generally validated the
underlying hypothesis that the fold-specifying and structure-
stabilizing residues occur with high frequencies in multiplets reserved
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2005; Davidson, 2006), conserved sequence features in a evolu-
tionary sequence profile reflect mixed information beyond just
structural determinants. Furthermore, the sequence analysis
becomes progressively ineffective for proteins with decreasing
coverage of related sequences. Hence, the bioinformatics meth-
odology is inapplicable for engineering in silico designed
proteins, for which related protein sequences do not exist in
protein sequence databases. In this regard, we used artificial
molecular evolution (Hsu et al., 2006 ; Sieber et al., 1998 ; Mich-
nickandSidhu, 2008) to select from randomcollections of combi-
natorial sequences for foldable sequences, for which the
conserved sequence features revealed only fold-specifying and
structure-stabilizing residues (Hsu et al., 2006). This process
not only mimics the evolution of protein sequences in nature,
but also the methodology was specific in elucidating key struc-
tural determinant residues under artificially controllable folding
conditions regardless of the availability of naturally occurring
related sequences.
The structural determinant information for Min-23 structure
was applied to designing cystine-stabilized proteinaceous
binders against human vascular endothelial growth factor
(VEGF-A) (Gatto and Cavalli, 2006). VEGF-A is a major proangio-
genesis protein secreted by tumor cells and binds to its receptor
(VEGFR2) and to neuropilin on endothelial cells to stimulate the
angiogenesis process (Folkman, 2007). Monoclonal antibody
trapping VEGF has been developed (bevacizumab, or Avastin
from Genentech/Roche) as an angiogenesis inhibitor, and has
demonstrated efficacy against colon cancer, non-small-cell
lung cancer, and breast cancer (Bergers and Hanahan, 2008).
With the molecular evolution and recombinant phage display
techniques, we demonstrated that cystine-stabilized minipro-
teins binding to VEGF-A could be readily obtained from the
protein libraries designed based on the structural determinants
for the scaffold structure.
RESULTS
Intact Fraction as a High-Throughput Protein
Stability Measurement
One key technique in the molecular evolution methodology for
stability engineering is the intact fraction measurement (Figure 1)
that quantifies the stability of a phage-displayed cystine-stabi-
lized protein on a high-throughput platform; the intact fraction
is the percentage of the phage-displayed proteins remaining
folded (intact) after the treatment of protein denaturants followed
by bovine factor Xa (fXa) digestion. The stability measure
required that the fXa cleavage site (-IEGR-) was embedded in
the displayed protein sequences, in such way that the site was
protected from fXa digestion in a cystine-stabilized structure
but became accessible for fXa cleavage upon protein unfolding.
In addition to the designated cutting site, no other fXa cleavable
sites should exist in the displayed sequences. As depicted in
Figure 1, the phage-displayed proteins were unfolded by guani-
dine hydrochloride (GdnHCl) in the presence of dithiothreitol
(DTT) or Tris(2-carboxyethyl)phosphine to reduce disulfide
bonds, followed by the N-ethylmaleimide (NEM) treatment to
block cysteines from reforming cystine-stabilized structure.
Only the GdnHCl/DTT-unfolded and NEM-blocked polypeptidesStructure 17were cleaved at the exposed cutting site (-IEGR-) by fXa, and
consequently the N-terminal hexa-His tag was removed from
the phage particle. The intact fraction was then determined by
a pair of enzyme-linked immunosorbent assays (ELISAs), which
determined the ratio of phages capable of binding to Ni2+-coated
surface from phage solutions before and after the fXa digestion.
Two control phages were constructed to validate the intact
fraction measurement. The pC-Xa phage (Figure 2) was the posi-
tive control, for which the displayed peptide mimics the exposed
fXa cutting site in a fully unfolded polypeptide appending to the
phage particle. As expected, the measured intact fractions were
all below 10% at various denaturant conditions (Figure 3A). In
contrast, the negative control pC-Min-23 phage (Figure 2) was
insensitive to the denaturant conditions and fXa digestion
(Figure 3A), indicating that no additional fXa cutting sites existed
Figure 1. Flow Chart Depicting Procedures for Library Selection,
Library Characterization, and Single-Colony Analysis
(1) Library selection: Phage-display library (depicted as the Eppendorf tube in
the lower part of the figure) is treated with denaturants followed by fXa diges-
tion. Phage particles with intact hexa-HIS tag are enriched with Ni-NTA beads.
The selected phage particles are amplified and used as input phage display
library for the next selection cycle.
(2) Library characterization: Phage display library (depicted as the Eppendorf
tube in the lower part of the figure) is treated with denaturants. The treated
phage solution is parted into two equal portions: one treated with fXa and
the other one used as control. The intact fraction is calculated as the ratio of
ELISA signal readouts from the fXa-treated portion over the control.
(3) Single-colony analysis: A single colony is picked from agarose plate and
phage particles are rescued and cultured overnight. The intact fraction of
the phage is determined as described in (2)., 620–631, April 15, 2009 ª2009 Elsevier Ltd All rights reserved 621
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measurements reflected only the cleavage of the -IEGR- site
between the pIII protein and the hexa-His tag.
Design of Cystine-Stabilized Scaffolds
for Phage Display
Three Min-23 variants with IEGR replacement for the residues
between cysteines (constructs pC-Mx13, Figure 2) showed
different stability under various denaturant conditions. The three
variants were equally stable in the presence of only fXa, indicating
thatdisulfidebondingeitherprotected the fXacleavagesiteorkept
the cleaved peptide fragments connected through the disulfide
linkage. In the presence of denaturants, pC-Mx2 remained stable
(Figure 3A) whereas the sequences of pC-Mx1 and pC-Mx3
yielded less stable structures (data not shown), in agreement
with the 1-3/2-4 disulfide bonding configuration of the Min-23
scaffold. This is because for the N-terminal HIS tag to be cleaved
from pC-Mx2, both disulfide bonds need to be disrupted
(assuming the 1-3/2-4 configuration); whereas for pC-Mx1 and
pC-Mx3, only one disulfide bond needs to be disrupted for the
N-terminal HIS tag cleavage. Thus, it was not unexpected that
pC-Mx2 was more stable than the other two phages in the pres-
ence of denaturant and fXa. In comparison, the stability of Mx2
Figure 2. Phagemid Constructs for Phage-
Displayed Proteins and Combinatorial
Libraries
DNA fragments were cloned with the pCANTAB5E
phagemid as shown. Restriction enzyme XbaI
(restriction site TCTAGT) and NotI (restriction site
GCGGCCGC)wereused for thecloningprocedure,
except for pC-Xa where SpeI (restriction site
ACTAGT) was used in place of XbaI. The DNA
fragments were inserted after the g3 signal
sequence,which isN-terminal to theE-tag followed
by the gene 3 in the pCANTAB5E phagemid.
was indistinguishable from that of Min-23
(Figure 3A). The stability of the Mx2 struc-
ture was expected: the local sequence
between the secondand the third cysteine
(-LAGS-) in Min-23 forms type II turn in the
EETI-II X-ray structure (Kratzner et al.,
2005) (Figure 4D). This local structure is
highly compatible with the fXa-cleavable
sequence (-IEGR-), as judged by the
sequence preferences for the tight turn in
known protein structures (Peng and Yang,
2007; Yang and Wang, 2003).
The structure of the refolded Mx2 poly-
peptide was determined with 2D nuclear
magnetic resonance (NMR) (Figure 4). As
shown in the superimposed structures
(Figure 4D), the structure of Mx2 is
similar to the corresponding domain in
the wild-type EETI-II X-ray structure; the
characteristic 1-3/2-4 disulfide bonding
configuration in Min-23 was conserved
in the Mx2 structure. To further confirm
the disulfide bonding configuration, we did the structure calcula-
tion for all 3 possible connectivities, the target functions were
4.28 3 102, 2.80 3 105, and 9.78 3 103 for (9-15, 21-27),
(9-21, 15-27), (9-27,15-21) in Mx2, respectively. Because the
lower target function indicates lower violations, these results
confirmed that (9-21, 15-27) was the most favorable configura-
tion for the disulfide bonds. The floating disulfide computation
also confirmed that the (9-21, 15-27) disulfide connectivity was
the most stable species.
To the limit of phage tolerance of 2MGdnHCl and 10mMDTT,
the intact fraction of the Mx2 phage was 78 ± 18% (Figure 3A).
To confirm this intact fraction as the ratio of folded over total
conformations, the refolded Mx2 polypeptide was treated with
2 M GdnHCl and 10 mM DTT for 30 min before measuring the
fraction of the folded conformation with reverse-phase high-
performance liquid chromatography (HPLC). The result showed
that 48% of the Mx2 polypeptide remained folded. The discrep-
ancy reflected the intrinsic differences between the twomethods
in measuring the fraction of the polypeptide remaining disulfide
bonded after the denaturant/protease treatment. The HPLC
methodmeasured the fraction of fully disulfide-bonded polypep-
tide, whereas the intact fractionmethod required that, in addition
to the reduction of the disulfide bonds, the IEGR site in the622 Structure 17, 620–631, April 15, 2009 ª2009 Elsevier Ltd All rights reserved
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Molecular Evolution of Cystine-Stabilized ProteinsFigure 3. Selection and Screening for Cystine-Stabilized Binders
against Human VEGF-A
(A) The histogram compares the intact fractions of controls and phage-
displayed libraries with (pC-68X) and without (pC-Lib13) the structural
determinant residues. The intact fractions were obtained after treatment of
2U of fXa for 2 hr (black bar); 10 mM DTT, 80 mM NEM, and 2U fXa for 2 hr
(white bar); 2M GdnHCl, 10mM DTT, 80 mM NEM, and 2U fXa for 2 hr (gray
bar). The standard deviations are shown as the error bars, calculated with
12 repeats of the measurements.
(B) Five pC-8X phage-displayed variants were selected from 48 randomly
picked phage colonies after two rounds of biopanning against human VEGF-A.Structure 17,reduced polypeptide displayed on the recombinant phage be
fully accessible to fXa protease digestion—any steric hindrance
against fXa to reach the fXa-cleavable sequence would result in
incomplete digestion and thus higher measured intact fraction
than the fraction measured by HPLC. Thus, the intact fraction
measurements can only be treated as a semiquantitative
measure for folding stability, suitable for high-throughput exper-
imental platforms, and the stability comparison based on the
intact fraction measurements needs to be carried out under
strictly consistent experimental conditions (see below).
Elucidation of Structural Determinant with Molecular
Evolution
With the Mx2 established as a stable template structure and
the fXa cleavage site fitfully embedded in the cystine-stabilized
scaffold, sequence requirements for the folding of the scaffold
structure were elucidated with the selection/amplification cycles
depicted in Figure 1. Two protein libraries were constructed
based on the pC-Mx2 template (pC-Lib1 and pC-Lib3 shown in
Figure 2). The libraries covered variants derived from degenerate
DNA codon replacements for the residues other than the fXa
cutting site and the cysteines with complexity greater than 108
each (Experimental Procedures), which was enough to cover all
possible variants (205) in each of the libraries. Phage-displayed
cystine-stabilized structures from the libraries were then enriched
with the selection/amplification cycles (Figure 1 and Experimental
Procedures). Figure 5 shows the intact fractions of the input
libraries under the selection conditions of the following selection
cycle. None of the denaturant conditions in Figure 5 affected the
infectivityof the recombinantphage to its hostE.coli. Theprogres-
sive resistance to the increasingly stringent denaturant conditions
(Figure 5) indicated that the selection procedure was effective in
enriching cystine-stabilized structures displayed on the recombi-
nant phage.Single colonieswere randomlypicked from thephage
libraries after the 0, 4th, and 8th selection cycle. The intact frac-
tions for each monoclonal displayed protein were determined
under three denaturant conditions: (1) GdnHCl (0 M) / DTT (0 M) /
NEM (0 M); (2) GdnHCl (0 M) / DTT (10 mM) / NEM (80 mM); (3)
GdnHCl (2 M) / DTT (10 mM) / NEM (80 mM). Tables S1 and S2
(available online) show total 237 sequences from pC-Lib1 and
pC-Lib3 and the intact fractions under the above denaturant
conditions. We clustered the phage-displayed proteins into four
classes with decreasing structural stability: class (+++), intact
The y axis shows the ELISA OD at 405 nm developed after the binding of
the phage variants to the wells coated with 1 mg VEGF-A, milk, bovine serum
albumin (BSA), fish gelatin, and hen lysozyme, respectively. All wells were
blocked with 3% fish gelatin before phage binding. The displayed sequences
for these variants are shown in Table 3. The stability class—e.g., (++), (+),
and ()—for each of the variants is labeled above the histogram based on
the intact fraction measurements as shown in panel (C). The error bars indi-
cated the standard deviations derived from four repeats of the measurements.
In addition to the five pC-8X variants, positive control was carried out with a re-
combinant phage displaying anti-VEGF antibody fragment scFv (Av1), for
which the phagemid was constructed based on the published sequence
(Fuh et al., 2006). The negative control (TAA) was carried out with null recombi-
nant phage containing only wild-type pIII capsid protein.
(C) The histogram shows intact fractions of the selected VEGF-binding variants
from pC-8X library (see panel [B]). The detailed experimental conditions are
described in Experimental Procedures. The error bars indicate the standard
deviations of the measurements with three repeats.620–631, April 15, 2009 ª2009 Elsevier Ltd All rights reserved 623
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Molecular Evolution of Cystine-Stabilized ProteinsFigure 4. Structure Determination of Mx2 with 2D NMR
(A) The amino acid sequence for Mx2 is LMRCKQDSDCIEGRVCGPNGFCG. The NOESY fingerprint region (upper panel) showed the NOE connectivity between
NH and HaHb. The Hb region (lower panel) indicated the disulfide bonding between Cys4-Cys16 (equivalent to Cys 9-Cys21 in EETI-II numbering) and Cys10-
Cys22 (equivalent to Cys 15-Cys27 in EETI-II numbering). More details of the NMR experimental conditions can be found in Experimental Procedures.
(B) The ensemble of 20 NMR structures of the refolded Mx2 polypeptide. Helices are colored in red, sheets in yellow, and turns in green. Disulfide bonds are
represented in orange sticks. The structure refinement details are shown in Table 1.
(C) This panel shows the side-by-side stereo display of the Mx2 structure.
(D) Superimposition of the Mx2 and NL3 (see Figure 6) structures with the parent protein EETI-II (Protein Data Bank code 1h9h) (Kratzner et al., 2005). The RMSD
of EETI-II (gray) with Mx2 (cyan) and NL3 (magenta) are 2.92 A˚ and 1.33 A˚, respectively.fractions were all above 70% for all three denaturant conditions;
class (++), intact fraction for denaturant condition (3) was below
70%, the other two denaturant conditionswere above 70%; class
(+), only the intact fraction for denaturant condition (1) was
above 70%; class (), none of the intact fractions were above
70% for all three denaturant conditions.
The intact fraction measurement uncertainty was determined
with six sets of experiments (two control phages: pC-Xa and624 Structure 17, 620–631, April 15, 2009 ª2009 Elsevier Ltd All righpC-Mx2 and three denaturant conditions as shown in Tables
S1 and S2). Each set of the experiments repeatedly measured
the intact fraction 20 times and calculated the standard devia-
tion. The largest standard deviation was 22%, measured with
pC-Mx2 phage in GdnHCl (2 M) / DTT (10 mM) / NEM (80 mM)
(Tables S1 and S2). Based on this standard deviation, any dis-
played polypeptide sequence with the intact fraction greater
than 70% is within the experimental error to have similar stabilityts reserved
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classify the polypeptide sequences as described above.
The LOGO plots in Figure 6 show the sequence preferences
for all the four stability classes from the pC-Lib1 and pC-Lib3
library respectively. The sequence preferences emerged in
Figure 6 are similar with corresponding parts of the evolutionarily
conserved sequence pattern (Figure S1): Among the pC-Lib1
(+++) members, the two most conserved residues (residues 12
and 14 in EETI-II numbering, see Figure 6) are in consensus
with the evolutionary sequence pattern, where these two resi-
dues are also highly conserved (Figure S1). Similar conclusions
applied to the sequence preferences among the pC-Lib3 (+++)
members. The two most conserved amino acids (residues
2526) are consistent with the two most conserved residues in
the homolog sequence-based sequence profile (Figure S1) in
the sequence ranging from residue 22 to residue 26. The
sequence preference features in the two (+++) classes became
progressively diminished with decreasing stability as evident in
the sequence profiles derived from the other three stability
classes (Figure 6). This result indicated that the sequence
features emerged in the (+++) classes are critical to the folding
and/or stability of the cystine-stabilized Mx2 structure.
To answer the question as to whether the sequences in the
(+++) class folded into cystine-stabilized structure with the 1-3/
2-4 disulfide bond configuration, we determined the structure
of refolded NL3 polypeptide with 2D NMR spectroscopy
(Figure 7). The sequence of NL3 (LMRCKQDSDCIEGRVCVDH
DYCG) is a (+++) class member from pC-Lib3 with very different
sequence from the (+++) class consensus sequence shown in
Figure 6. Even so, the NMR structures (Figure 7) are similar to
the Mx2 structure and the parent structure EETI-II (Figure 4D)
in both general folding topology and the disulfide bond configu-
ration. To further confirm the disulfide bonding configuration, we
Figure 5. Progressive Resistance of the Phage-Displayed Libraries
against Increasingly Stringent Denaturant Conditions at Each Selec-
tion/Amplification Cycle
The y axis shows the intact fraction of the input library under the selection
condition of each selection cycle in the x axis: first round, DTT/NEM; 2nd round,
GdnHCl (2 M) / DTT / NEM; 3rd round, GdnHCl (4 M) / TCEP gel / NEM; fourth
through eighth rounds, GdnHCl (6 M) / TCEP gel / NEM, where DTT and NEM
were kept at 10mM and 80mM, respectively. None of these denaturant condi-
tions affected the infectivity of the recombinant phages within two orders of
magnitude in colony forming units.Structure 17did the structure calculation for all 3 possible connectivities, the
target functions were 2.7 3 101,8.7 3 102, and 1.8 3 101 for
(9-15, 21-27), (9-21, 15-27), (9-27,15-21), respectively. These
results confirmed that (9-21, 15-27) was the most favorable
configuration for the disulfide bonds.
Cystine-Stabilized Phage Display Libraries
for VEGF-A Binding
The sequence profiles shown in Figure 6 provided structural
determinant information in cystine-stabilized phage-displayed
library constructs. In particular, Asp12, Asp14, Gly25, and Phe26
are the structural determinant residues for the scaffold structure
and should remain invariable in the library designs. Based on
this insight, three libraries (pC-6XpC-8X, see Figure 2) were
Figure 6. Sequence Profiles for the Sequences from pC-Lib1 and
pC-Lib3 with Decreasing Structural Stability
The corresponding sequences and detailed stability measurements are listed
in Table S1 (pC-Lib1) and S2 (pC-Lib3). For pC-Lib3 sequences, entries with
more than two His in the sequence shown in Table S2 were not included as
part of the sequence profile. The reason is that these sequences could be
selected by Ni-NTA binding owing to the His-rich sequence rather than the
hexa-His tag designed for the selection of the stable structures. This situation
is not applicable to sequence members from pC-Lib1.The logo plots were
generated by the WebLogo program (http://weblogo.berkeley.edu/) (Crooks
et al., 2004) with the background amino acid occurrence frequencies in consis-
tent with the degenerate codons used in the phage display system as shown in
Figure 2. See Table S3 for the list of the amino acid occurrence frequencies., 620–631, April 15, 2009 ª2009 Elsevier Ltd All rights reserved 625
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Molecular Evolution of Cystine-Stabilized ProteinsFigure 7. Structure Determination of NL3 with 2D NMR
(A) The amino acid sequence for NL3 is LMRCKQDSDCIEGRVCVDHDYCG. The fingerprint region (upper panel) showed the NOE connectivity between NH and
HaHb. The Hb region (lower panel) indicated the disulfide bonding between Cys4-Cys16 (equivalent to Cys 9-Cys21 in EETI-II numbering). The second disulfide
link Cys10-Cys22 (equivalent to Cys15–Cys27 in EETI-II numbering) was not resolved in the NMR spectra but mass spectroscopy analysis indicated that two
disulfide bonds were evident in NL3, suggesting that the Cys10-Cys22 disulfide bond was also formed. More details of the NMR experimental conditions can
be found in Experimental Procedures.
(B) The ensemble of 20 NMR structures of the refolded NL3 polypeptide. Helices are colored in red, sheets in yellow, and turns in green. Disulfide bonds are
represented in orange sticks. The structure refinement details are shown in Table 2.
(C) This panel shows the side-by-side stereo display of the NL3 structure. The side chains of the variable residues in the pC-6X library are shown in the space-
filling model, and form a contiguous protein-recognition surface on the scaffold.constructed. The intact fractions at variousdenaturant conditions
were compared among the libraries (Figure 3A). As expected, the
pC-6XpC-8X libraries indeedcontainedmorecystine-stabilized
phage-displayed proteins than the libraries constructed without
considering the structural determinant residues (pC-Lib1 and
pC-Lib3, Figure 3A). Moreover, the stabilities of the displayed
proteins decreases with increasing loop size between the third
and the fourth cysteine, suggesting that the elucidated structural
determinant residues were more relevant to the original loop size
in the Mx2 structure.
The binding properties of variants in pC-8X were further tested
against human VEGF-A. Specific phage displayed binders were
identified after only two selection cycles (Figure 3B). Even though
pC-8X contained the least abundant cystine-stabilized variants626 Structure 17, 620–631, April 15, 2009 ª2009 Elsevier Ltd All righamong the three libraries, four (one in ++ and three in (+)
stability class; Figures 3B and 3C) of the five randomly picked
VEGF binders as shown in Figure 3B formed disulfide linkages
to stabilize the proteinaceous binders. In comparison, the affin-
ities toward VEGF-A were comparable between the selected
pC-8X variants and the anti-VEGF antibody fragment scFv
(data for Av1 in Figure 3B), but the anti-VEGF scFv (Av1) was
relatively more specific in VEGF recognition than the pC-8X vari-
ants (Figure 3B).
DISCUSSION
The 23-residue autonomous folding unit (Min-23) from EETI-II is
the smallest cystine-stabilized beta-sheet (CSB) motif knownts reserved
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nizing sequence-structure relationships governing the folding of
the motif. The small protein class in SCOP database (Murzin
et al., 1995) is composed of 85 folds to date. More than half of
these folds belong to disulfide-rich families. Nearly 50% of the
disulfide-rich families contain a CSB motif (Souriau et al., 2005).
The prevalence of the motif resulting from convergent evolution
and the permissiveness in sequence requirements makes the
CSBappealing as an ideal scaffold for protein engineering,where
sequence tolerance and folding stability/specificity need to
coexist. Still, the structural determinants for the CSB are largely
unknown. The information is critical not only for understanding
the structural determinants in the folding of the CSB, but also
in designing combinatorial libraries with variants retaining the
CSB structure.
Even with the small size of Min-23, the potential sequence
variation of the noncysteine residues is still astronomically vast
(2019 variants), and hence neither experimental nor computa-
tional methodologies provide effective means to comprehen-
sively elucidate the sequence-structure relationships of the
protein. In this study, we constructed combinatorial protein
libraries to exhaustively explore the sequence requirements
within two consecutive 5-residue sequence segments of
Min-23. The complexities of the combinatorial libraries
(108109) was enough to cover all the possible variants in these
Table 1. Summary of Structural Constraints and Structural
Statistics Derived from 2D NMR for Mx2
NMR Distance and Dihedral Constraints
Distance constraints
Total NOE 106
Intraresidue 48
Interresidue 58
Sequential (ji-jj = 1) 43
Medium range (ji-jj < 4) 8
Long range (ji-jj > 5) 7
Hydrogen bonds 4
Total dihedral angle restraints 9
Phi 9
Structure Statistics from CYANA
Target function (A˚2) 2.8E-05
Average upper distance limit (A˚) 0.0001
Average dihedral angle constraints () 0.0016
Maximum dihedral angle violation () 0.05
Maximum upper distance limit (A˚) 0.01
Average pairwise rmsda (A˚)
Heavy 0.95 ± 0.16
Backbone 0.53 ± 0.15
Ramachandran analysis
Most favorable region 72.1%
Additional allowed regions 27.9%
Generally allowed regions 0%
Nonfavorable region 0%
aPairwise root-mean-square deviation was calculated among 20 refined
structures for secondary structure region (7–10, 15 and 16, 22 and 23).Structure 17sequence segments (205). The first segment is the sequence
between the first (Cys9) and the second cysteine (Cys15); the
second segment is the sequence between the third (Cys21)
and the fourth (Cys27). These two segments are important struc-
tural regions (310 helix and type I beta-turn, respectively), and
are known to involve in the folding initiation or specification of
the CSB motif (Heitz et al., 1995, 1999; Wentzel et al., 1999).
We are particularly interested in these two regions because
our design of antibody mimetics based on the Min-23 scaffold
required that the sequence in these two regions to be
replaced by hypervariable loops mimicking the CDRs in the anti-
body—we needed to know which residues in these regions are
structural determinants that are irreplaceable if the CSB fold is to
be retained.
The limitation of the current experimental design is that the
structure-wisestable variantswithsequencevariegationbetween
Cys9 and Cys15 were evolved in the context of the wild-type
sequence between Cys21 and Cys27. Similarly, the stabilizing
Table 2. Summary of Structural Constraints and Structural
Statistics Derived from 2D NMR for NL3
NMR Distance and Dihedral Constraints
Distance constraints
Total NOE 183
Intraresidue 64
Interresidue 119
Sequential (ji  jj = 1) 66
Medium range (ji  jj < 4) 29
Long range (ji  j > 5) 24
Hydrogen bonds 2
Structure Statistics from CYANA
Target function (A˚2) 8.71 E-02
Average upper distance limit (A˚) 0.10
Maximum upper distance limit (A˚) 0.13
Average pairwise rmsda (A˚)
Heavy 0.69 ± 0.38
Backbone 0.29 ± 0.11
Ramachandran analysis
Most favorable region 63.5%
Additional allowed regions 36.0%
Generally allowed regions 0.5%
Nonfavorable region 0%
aPairwise rmsd was calculated among 20 refined structures for
secondary structure region (7–10, 15 and 16, 22 and 23).
Table 3. Phage-Displayed Sequences of Randomly Picked
Binders against Human VEGF-A from pC-8X Library
8x-2A L M R C R S D A D C I E G R V C S Y F S Q G F C G
8x-2C L M R C T S D L D C I E G R V C A AW L S G F C G
8x-2D L M R C G S D S D C I E G R V C P P S R SG F C G
8x-5D L M R C L S D P D C I E G R V C P S L S L G F C G
8x-7E L M R C L F D L D C I E G R V C S FW P R G F C G
The bold characters represent the variable regions in phage-displayed
protein library design., 620–631, April 15, 2009 ª2009 Elsevier Ltd All rights reserved 627
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context of the wild-type sequence between Cys9 and Cys15.
Thus, the resultant stabilizing sequences have been expected
to vary around the local sequence space optimumcorresponding
to the wild-type sequence of Min-23. This expectation was
confirmed by comparing the sequence profiles shown in Figure 6
and Figure S1. The consistency of the two sets of sequence
profiles have supported the validity of the artificial molecular
evolution methodology presented in this work. Nevertheless,
experimental designs with co-evolution of both sequence
segments would provide more complete sequence-structure
relationships outside thewild-type local optimum in the sequence
space. But such experiments would need phage display libraries
to cover at least 2010 complexity, which is about four orders of
magnitude beyond current complexity limitation in phage-dis-
played protein libraries.
The combinatorial exploration for structural determinants in
these two regions revealed that Asp12 and Asp14 between
Cys9 and Cys15 were consensus residues in the cystine-stabi-
lized structures. Gly25, and Phe26 to a lesser degree, were
consensus residues between Cys21 and Cys27 in the cystine-
stabilized structures. In the former region, the Asp12 side-chain
carboxyl group is hydrogen bondedwith the backboneNHgroup
of Cys21 and the Asp14 side-chain carboxyl group is hydrogen
bonded with the backbone NH group of Lys10 according to the
X-ray structure of EETI-II (Kratzner et al., 2005). Moreover, the
Asp14 has high propensity to adopt a type I turn as needed in
the local structure. In the latter region, Gly25 (backbone torsion
angle in the aL region) is a critical residue for the local tight
turn structure and Phe26 involves in tertiary interactions with
Leu7 and Arg9. Other than these consensus residues, the rest
of the residues in the 310 helix structure in the former region
and the type I tight turn of the latter region were permissive
and could be because the torsion angle requirements for these
structures can be accommodated by all amino acids. The struc-
ture of NL3 (Figure 7), however, indicated that sequenceswithout
the consensus sequence features could still form the native
structures, although sequences matched with the sequence
features above were preferred in folding into stable native
structure.
The structure determinant information abovewas derived from
large scale experiments on stability determination. Large scale
experimental methods in elucidating structure-stabilizing and
fold-specifying residues require a selection method to isolate
folded structures from unfolded ones and a high-throughput
measurement for the stability of each of themonoclonal proteins.
Experimental methods based on enzyme digestion or binding
specificity have been developed to select for stable structures
from protein display systems (see reviews Kotz et al., 2004;
Magliery and Regan, 2004). But high-throughput measurements
for the stabilities of the displayed proteins have received less
attention, perhaps because of experimental limitations in high-
throughput protein expression and in high-throughput protein
stability measurement with conventional experimental tech-
niques (Aucamp et al., 2005; Bommarius et al., 2006). The intact
fraction measurement described in this work provides a general
strategy for high-throughput stability measurements of cystine-
stabilized protein structures. The correlation of the sequence
features and the structural stability indicated that the intact628 Structure 17, 620–631, April 15, 2009 ª2009 Elsevier Ltd All righfraction measurements closely reflected the stabilities of the
phage-displayed proteins.
This high-throughputmethodology is subject to the concentra-
tion limit of the denaturants tolerated by the recombinant phage
(2 M GdnHCl and 10mM DTT). Structural stability above this
denaturant threshold cannot be discriminated with this method.
Hence, themost effective application of themethod is to discrim-
inate disulfide-linked structures with well-buried disulfide bonds
from protein structures with surface disulfide bonds found in
scrambled cysteine-rich structures. This is particularly feasible
in small CSB structures. In the Mx2-based combinatorial
libraries, three two-disulfidebonding configurations are possible:
(9-21,15-27), (9-15,21-27), and (9-27,15-21).With fXa cutting site
situated between Cys15 and Cys21, the (9-15,21-27) species is
cleavable by fXa without the disulfide bond reduction, so that
these species should belong to the () class. The (9-27,15-21)
species have both disulfide bonds exposed to solvent due to
lacking the interlocking cystine structure and the small size of
the miniprotein. This conclusion was derived from a molecular
simulation of the model structures, for which the simulation
details and results are shown in theFigureS2. The simulation indi-
cated that the (9-27,15-21) conformation was less capable of
sequestering the disulfide bonds from the water environment
than the native NMR structure of Mx2. The (9-27,15-21) species
is cleavable by fXa after the DTT reduction and NEM blocking,
and should belong to the (+) class. Only the native configura-
tion (9-21,15-27) is resistant to DTT/NEM/fXa treatment and can
be unfolded in the presence of both GdnHCl and DTT. These
species should belong to either (++) or (+++) class, as demon-
strated inMx2 andNL3molecules by the structure determination
(Figures 4 and 7) and the intact fraction measurements at various
denaturant conditions (Figure 3A and Table S2).
The selection/amplification cycles basedon the sameprinciple
as in the intact fraction measurement (Figure 1) were effective in
enriching variants that were resistant to increasingly stringent
denaturant conditions. In combination with the high-throughput
intact fraction measurements for monoclonal protein stability
analysis, the artificial evolution procedure generated sequence
profiles for the variants clustered according to the structural
stability against denaturants and fXa digestion (Figure 6). Unlike
sequence profiles derived from homologous proteins that have
been evolved from single or multiple ancestors to accomplish
structural stability in a natural environment, these sequence
profiles revealed the emergence of the sequence patterns as
the variant structures becoming more accommodating to artifi-
cial stability conditions. Comparing the emerged consensus
sequence profiles from directed evolution (Figure 6, class [++]
and [+++]) with the sequence profile from natural homologous
sequences (Figure S1), we found that the sequence patterns in
the corresponding areas were strikingly similar. The consistency
has confirmed the underlying hypothesis for the consensus-
based protein engineering approach, where amino acid residues
specifying the fold and stabilizing the structure occur in higher
frequency in the evolution-derived sequence profiles. More
importantly, the artificial evolution methodology can be applied
to artificially designed proteins for which the homologous protein
sequences are not available in nature. In this work, we initiated
a methodology to design small cystine-stabilized proteins
without the need to start with a known sequence in nature. Withts reserved
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the basic requirements in the sequences for designated struc-
tural details and then artificially evolve the variants to find the
sequence requirements that have or have not been attained in
the initial in silico design of a stable structure.
The sequence requirements for a stable structure are prereq-
uisites for designing protein binders with paratopes composed
of nonsequential protein segments. This type of conformational
paratope is known to confer the combinatorial power to anti-
body-antigen recognitions. In designing the two-loop variable
surfaces (Figure 7C) on the Mx2 scaffold, the structural determi-
nant residues discussed above remained invariable, and indeed
the variants designed as such are benefited in structural stability
from these key residues (Figure 3A). The structural stability in
turn increases the binding affinity in tentative protein-recognition
complexes, and thus we anticipated to identify binders with
reasonable binding affinity/specificity (Figure 3B) and structure
stability (Figure 3C).
VEGF-A antagonists have potential therapeutic applications.
The stabilization of known peptide VEGF-A epitope has recently
been accomplished by Gunasekera et al. (2008) through grafting
VEGF-A binding peptide onto a plant-derived cyclotide scaffold
with three conserved disulfide bonds, which confer the extraordi-
nary stability of the cyclotide. We demonstrated in this work that
alternative potential VEGF-A binders can be derived on the basis
of a cystine-stabilized miniprotein scaffold from a phage-dis-
playedprotein library,where stabilizing disulfidebonding configu-
rationhasbeenspecifically designedandselected to formastable
structure with required binding specificity.
In summary, with the fXa cutting site embedded in the
sequences of the Mx2-based libraries, molecular evolution with
both binding-selection against the target protein and stability-
selectionagainst fXadigestionafterdenaturant treatmentenabled
aproteinengineeringproceduresimultaneouslyenhancing recog-
nition specificity and structural stability for the cystine-stabilized
binders. Thismethodology canbe generalized to engineering arti-
ficial minisequences initially designed in silico.
EXPERIMENTAL PROCEDURES
Phage Display Library Construction
pCANTAB5E (GE-Amersham) phagemids for recombinant M13KE phage
particles displaying various polypeptide sequences and libraries on the minor
capsid pIII protein were constructed as shown in Figure 2. The phagemid
templates with the TAA stop codons in the sites for amino acid randomization
(i.e., pC-Mx2_TAA1, pC-Mx2_TAA3, pC-nX_TAA in Figure 2) were designed to
ensure that only the library phagemids with designated degenerate codon
replacement would produce pIII fusion proteins for phage surface display.
The phage display libraries were constructed on the basis of these TAA-
templates with the oligonucleotide-directed mutagenesis method initially
proposed by Kunkel et al. (1987). In this work, we followed the protocol of
Sidhu and Weiss (2004). Details of the methodology have been described in
Hsu et al. (2008). Sequences for the DNA primers are listed in Supplemental
Experimental Procedures. The complexities of the libraries were 4.4 3 108,
5.0 3 108, 2.4 3 109, 7.0 3 108, and 1.5 3 109 for pC-Lib1, pC-Lib3, pC-6X,
pC-7X, and pC-8X, respectively.
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The 10 ml rescued recombinant phage particles (1011 cfu/ml) were precipi-
tated with PEG/NaCl (20% PEG 8000 and 2.5 M NaCl) and then resuspended
in 100 ml phosphate buffer (50 mM NaH2PO4, 300 mM NaCl [pH 8.0]) with
concentration of GdnHCl ranging from 0 M to 2 M. Dithiothreitol was addedStructure 17to the phage solution tomake final concentration of 10mM for 20min, followed
by adding NEM to the solution tomake final concentration of 80mM for 30min.
Both reactions were carried out at room temperature. GdnHCl and DTT were
used to unfold the polypeptide chain and to reduce disulfide bonds in the
displayed proteins; reaction of excessive NEM with the thiol group in free
cysteines blocked the reformation of disulfide bonds in the displayed proteins.
After the reaction, the phage particles were precipitated with 20% PEG/NaCl
and resuspended in 60 ml bovine fXa reaction buffer (20 mM Tris-HCl [pH 6.8],
50 mM NaCl, 1 mM CaCl2) containing 2 units fXa (QIAGEN) for 1 hr at room
temperature.More than 90%of the cleavable sites engineered in the displayed
proteins that were unfolded by the GdnHCl/DTT/NEM treatment were cleaved
and the hexa-His tags were removed from the phage particles. The well-folded
proteins with protected disulfide bonds remained intact with the hexa-His tag
and the intact recombinant phages were isolated through binding to Ni-NTA
beads. This was done by adding the reaction mixture to 1ml of Ni-NTA binding
buffer (50 mM NaH2PO4, 300 mM NaCl [pH 8.0]) containing 50 ml Ni-NTA
agarose beads (QIAGEN) for 1 hr. The Ni-NTA beads were transferred to
a micro filter (Millipore Ultrafree MC, UFC30SV00) and washed 21 times,
each with 500 ml washing buffer (50 mM NaH2PO4, 300 mM NaCl [pH 8.0],
10 mM imidazole). The Ni-NTA bound phage particles were then eluted
from the Ni-NTA beads with elution buffer (50 mM NaH2PO4, 300 mM NaCl,
[pH 8.0], 200 mM imidazole). The eluted phage particles were amplified
overnight and were used for the next round of selection.
The above selection protocol is not suitable for GdnHCl concentration higher
than 3 M because few phage particles remained infective after the GdnHCl/
DTT/NEM treatment above the 3MGdnHCl threshold concentration.We found
that immobilized TCEP (Tris(2-carboxyethyl)phosphine on agarose bead,
Pierce product #77712) reduced disulfide bonds to less extent than 10 mM
DTT but had much less adverse effect on phage infectivity in the presence of
a high concentration of GdnHCl up to 6M. The GdnHCl/TCEP-gel/NEM-based
selection was different from the GdnHCl/DTT/NEM-based selection described
above in only one step: instead of adding DTT followed by NEM to the phage
solution, we added 100 ml TCEP gel to 100 ml phage solution (100 mM Tris-
acetate, 10 ml EDTA [pH 8]) in the presence of GdnHCl (36 M) and 80 mM
NEM. The reaction mixture was mildly rocked for 1 hr at room temperature
before fXa digestion as described above.
Intact Fraction Measurement
Mid-log E. coli ER2738 infected with the selected phage from the selection
procedure was spread on 2YT/ampicillin(100 mg/ml) agarose plate. Overnight
colonies were picked with GENETIX Qpix II colony picker to 96-well deep well
cultureplate. Eachwell contained1ml2YT,ampicillin 100mg, and108 cfuhelper
phage M13KO7. One hour after inoculation, 200 ml 2YT with 300 mg/ml kana-
mycin and 600 mg/ml ampicillin were added to each well. The culture plates
were incubated in 37C with vigorous shaking overnight. The overnight culture
was centrifuged at 3000 g at 4C for 30min. Then 100 ml supernatant from each
well was added to the correspondingwell of a 96-well His-sorb plate (QIAGEN).
After 1 hr of binding at room temperature, theHis-sorbplateswerewashedwith
33 250 ml PBST (phosphate-buffered saline [pH 7.5], Tween 20 0.05%washed
three times, each time with 250 ml) and 13 250 ml PBS. Anti-M13-HRP (1:5000,
GE-Amersham) in PBS+ skimmilk (2.5%)was added to eachwell for 1 hr. Clear
the anti-M13-HRP from theHis-sorb plateswith 33 250 ml PBST and 13 250 ml
PBS washing buffer. Then 100 ml ABTS substrate (BioFix) was added to each
well for 10 min before adding 1% (final concentration) SDS to terminate the
chromogenic reaction. The optical density (OD) of each well was measured at
405 nm. Phage species with OD405nm greater than 0.5 were selected for
measuring the extent of unfolding after the GdnHCl/DTT/NEM treatment (see
below). If the OD405nm was greater than 2, dilution was necessary so that the
quantitative ELISA readings (see below) remained linearly related to the
concentration of the phage particles with intact hexa-His tag.
For each of the selected phage solutions from the deepwell culture plate, the
phage solutionwas centrifuged at 8100 g in amicrocentrifuge tube. Then 200 ml
of the supernatant was transferred to a centrifugal filter (Millipore microcon
YM-100, molecular weight cut-off 100 kDa) and spun at 6600 g for 5 min to re-
movephageculturemedium.All recombinant phageparticleswere expected to
remain in the filter. The filter was washed with 200 ml phosphate buffer (50 mM
NaH2PO4, 300mMNaCl [pH 8.0]). After removing thewash buffer by centrifuge
(6600g, 5min), 100ml fXa reactionbuffer containingGdnHCl (02M)and10mM, 620–631, April 15, 2009 ª2009 Elsevier Ltd All rights reserved 629
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tration 80 mM) to the filter for 30 min. The reaction mixture was removed from
phage particles by centrifuge and by washing the filter two times, each with
200 ml fXa reaction buffer. The phage particles were then transferred from the
filter to amicro tubebyadding35ml fXa reactionbuffer to the filter andcollecting
the solution by centrifuging (2000 g, 2 min) the upside-down filter in the collec-
tion tube. Then 10 ml of the collected phage solution was added to a well of
a nonabsorbing plate containing 90 ml fXa reaction buffer and 0.2 U fXa. In
a secondwell of the sameplate, 10ml of the collectedphage solutionwasadded
to 90 ml fXa reaction buffer without fXa. After 2 hr reaction at room temperature,
50 ml of 1.5 M GdnHCl was added to all wells to terminate the enzymatic reac-
tion. Then 100 ml solution was transferred from each well to a corresponding
well in a His-sorb plate and the ELISA procedure was performed as described
above. The intact fraction was calculated with the OD405nm from the sample
with fXa over the OD405nm from the sample without fXa.
The library characterization procedure is similar to the single-colony anal-
ysis: the amplified phage library was precipitated with PEG/NaCl and then
treated with GdnHCl/DTT(or TCEP-gel)/NEM as described above. After the
denaturation reaction, the phage particles were isolated from the reaction
mixture with PEG/NaCl precipitation and were partitioned into two equal
portions, one treated with fXa and the other added only buffer. The intact
fraction of the phage particles after the GdnHCl/DTT (or TCEP-gel)/NEM/fXa
treatment was evaluated with the ELISA procedure described above.
Biopanning of Phage Library to VEGF-Conjugated Bead
AfterPEG/NaClprecipitation,phagesweredissolved inPBSTmilk (1012cfu/ml)
and incubated at room temperature for 30 min. Nonspecificity binding phages
were removed first by incubating the phages with ethanol-amine blocked
Ultralink Biosupport bead (Pierce) at 4C for 2 hr. The supernatant was trans-
ferred to the VEGF-A conjugated Ultralink Biosupport bead and incubated at
4C for 2 hr. The expression and purification of human VEGF-A are described
below. Thebeadswerewashed103 1mlPBST (0.05%Tween 20 in PBSbuffer)
and431mlPBS. TheVEGFbinding phageswere thenelutedwithglycinebuffer
(0.2M [pH2.0]). TheelutedphageswereneutralizedwithTris buffer (1M [pH9.1])
and then added into the fresh E. coli host ER2738 for reamplification.
Peptide Synthesis, Purification, and Refolding
Peptides were synthesized with automated solid-phase 9-fluorenymethoxy-
carbonyl peptide synthesizer. Lyophilized crude synthetic peptide was dis-
solved in 10 ml reducing buffer (100 mM Tris, 6 M GdnHCl, 100 mM DTT,
1 mM EDTA [pH 8.0]) at room temperature for 2 hr. The solution was titrated
with acetic acid to pH 3 and injected into reverse-phase HPLC to purify the fully
reducedpolypeptide,whichwas identifiedwithmass spectrometry. The aceto-
nitrile in the collected fraction was removed by lyophilization, and the polypep-
tide was redissolved in refolding buffer (100 mM Tris, 1 mM EDTA, 0.5 M
GdnHCl, 10mM reducedglutathione, 1mMoxidized glutathione [pH 8.5]) over-
night at 4C. The refolded polypeptide was isolated with reverse-phase HPLC.
The fraction containing the fully refolded polypeptide with two pairs of disulfide
bonds was identified by mass spectrometry. The actual disulfide bonding
configuration and the 3D structures were determined with 2D NMR.
Synthetic Peptide Structure Determination with 2D NMR
The purified refolded polypeptide as described above was dissolved in 90%
H2O and 10%D2O at pH 3 to final concentration of 1mM. All NMR experiments
were carried out at 285 K or 298 K on the Bruker Avance 600MHz spectrom-
eter. Assignment of 1H chemical shifts were based on 2D DQF-correlated
spectroscopy (COSY), total correlation spectroscopy (TOCSY), and nuclear
Overhauser enhancement spectroscopy (NOESY) experiments where water
suppression was achieved using 3-9-19 pulse sequence with gradients.
TOCSY spin lock was 70 ms, and NOESY spectra were collected with mixing
time of 150 ms and 300 ms. All data were acquired and processed using
TOPSPIN (Bruker, Germany) and further analyzed using Sparky software
package (T. D. Goddard and D. G. Kneller, SPARKY 3, University of California,
San Francisco).
Structure calculation was done using CYANA (Guntert, 2004) where simu-
lated annealing protocol with torsion angle molecular dynamics was applied.
Semiautomated NOE cross-peak assignments were performed using CANDID
module in the CYANA software and manually checked for correctness in an630 Structure 17, 620–631, April 15, 2009 ª2009 Elsevier Ltd All righiterative manner. The 3JNHa coupling constants estimated from DQF-COSY
spectra were converted to backbone f angles. These f angles were con-
strained in the range of 110 ± 30 for residues with 3JNHa coupling constants
larger than 9 Hz. Disulfide bond constraints were based on NOE observation
between Hb of Cys residues, and the distance upper limit between sulfur
atoms of disulfide bridges was set to 2.1 A˚. One hundred random conformers
were annealed in 10,000 steps for seven cycles and 20 structures with the
lowest target function after the final cycle were selected.
VEGF Expression and Purification
Human VEGF-A DNA encoding amino acid sequence 34–135 was synthesized
in fragments and jointed with recursive polymerase chain reaction. The synthe-
sized gene was constructed into pET15b vector and transformed to E. coli
strain BL21. A single colonywaspicked and cultured in 3ml Luria-Bertani Broth
(LB) / ampicillin (100 ug/ml) medium at 37C overnight. 1ml overnight culture
was poured into 1 l LB/ampicillin medium and incubated at 37C for 3–4 hr until
the OD595 reached to 0.60.8. The cells were inducted by 1 mM IPTG at 37C
for 3–4 hr and harvested by centrifugation at 4500 g for 20 min. The lysed cell
was centrifuged and the pellet was dissolved in denaturing buffer (20 mM
Tris, 8 M urea, 20 mM DTT [pH 7.5]). The protein solution was dialyzed against
thebuffer (20mMTris, 2Murea, 1mMcysteine [pH8.]) for 6 hr, and thenagainst
the buffer (20 mM Tris, 400 mM NaCl [pH 8.0]) overnight. The refolded protein
was purified with Ni-NTA resin (QIAGEN). The purified protein solution was
dialyzed against PBS buffer for 6 hr and exposed to open air for disulfide
mediated dimerization.
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